Irodalom
1. ALEXANDER HR JR, LIBUTTI SK, PINGPUNK JF. ET AL: Isolated hepatic perfusion for the treatment
of patients with colorectal cancer liver metastases after irinotecan-based therapy. Ann Surg
Oncol. 2005 Feb;12(2):138-44.
2. BARBARE JC, BOUCHE O, BONNETAIN F. ET AL: Randomized controlled trial of tamoxifen in advanced
hepatocellular carcinoma. J Clin Oncol. 2005 Jul 1;23(19):4338-46.
3. CAPPA FM, CANTARINI MC, MAGINI G.ET AL: Effect of the combined treatment with thalidomide,
megestrol and interleukine-2 in cirrhotic patients with advanced hepatocellular carcinoma. A
pilot study. Dig Liver Dis. 2005 Apr;37(4):254-9.
4. CHENG PN, LEUNG YC, LO WH. ET AL: Remission of hepatocellular carcinoma with arginine
depletion induced by systemic relaese of endogenous hepatic arginase due to transhepatic
arterial embolisation, augmented by high-dose insulin: arginase as a potential drug candidate
for hepatocellular carcinoma. Cancer Lett. 2005 Jun 16;224(1):67-80.
5. DENECKE T, HILDEBRANDT B, LEHMKUHL L. ET AL.: Fusion imaging using a hybrid SPECT-CT camera
imporves port perfusion scintigraphy for control of hepatic arterial infusion of chemotherapy
in colorectal cancer parients. Eut J Nucl Med Mol Imaging. 2005 Sep;32(9):1003-10.
6. DUCREUS M, YCHOU M, LAPLANCHE A, GAMELIN F. ET AL: gastrointestinal group of the Federation
Nationale des Centres de Lutte Contre le Cancer: Hepatic arterial oxaliplatin infusion plus
intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of
the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.
J Clin Oncol. 2005. Aug 1;23(22):4881-7.
7. DUCREUX M, YCHOU M, LAPLANCHE A.ET AL: Hepatic arterial oxaliplatin infusion plus intravenous
chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the
gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. J
Clin Oncol. 2005.Aug 1;23(22):4881-7.
8. ECKEL F, VON DELIUS S, MAYR M. ET AL: Pharmacokinetic and clinical phase II trial of imatinib
in patients with impaired liver function and advanced hepatocellular carcinoma. Oncology.
2005;69(5):363-71.
9. FAN J, ZHOU J, WU ZQ.ET AL: Effi cacy of different treatment strategies for hepatocellular
carcionoma with portal vein tumor thrombosis. World J Gastroenterol. 2005 Feb
28;11(8):1215-9.
10. GIANNELLI G, MARINOSCI F, SGARRA C.ET AL: Clinical role of tissue and serum levels of SCCA antigen
in hepatocellular carcinoma. Int J Cancer. 2005 Sep 10;116(4):579-83.
A máj | 287
288 | Gastro Update 2006
11. HUNG CH, LEE CM, WANG JH ET AL: Antiviral therapy after non-surgical tumor ablation in patients
with hepatocellular carcinoma associated with hepatitis C virus. J Gastroenterol Hepatol. 2005
Oct;20(10):1553-9.
12. IKEDA M, OKUSAKA T, UENO H ET AL: A phase II trial of continuous infusion of 5-fl uorouracil,
mitoxantrone, and cisplatin for metastatic hepatocellular carcionoma. Cancer. 2005 Feb
15;103(4):756-62.
13. KAWASHIMA M, FURUSE J, NISHIO T.ET AL: Phase II study of radiotherapy employing proton beam for
hepatocellular carcinoma. J Clin Oncol. 2005 Mar 20;23(9):1839-46.
14. KEMENY N, JARNAGIN W, PATY P. ET AL.: Phase I trial of systemic oxaliplatin combination chemotherapy
with hepatic arterial infusion in patients with unresectable liver metastases from colorectal
cancer. J Clin Oncol. 2005. Aug 1;23(22):4888-96.
15. KEMENY N, EID A, STOCKMAN J. ET AL: Hepatic arterial infusion of fl oxuridine and dexamethasone
plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal
carcinoma. J Surg Oncol. 2005 Aug 1;91(2):97-101.
16. KEMENY N, JARNAGIN W, PATY P.ET AL: Phase I trial of systemic oxaliplatin combination chemotherapy
with hepatic arterial infusion in patients with unresectable liver metastases from colorectal
cancer. J Clin Oncol. 2005 Aug 1;23(22):4888-96.
17. LAMBERT B, BACHER K, DE KEUKELEIRE K. ET AL: 188Re-HDD/lipiodol for treatment of hepatocellular
carcinoma: a feasibility study in patients with advanced cirrhosis. J Nucl Med. 2005
Aug;46(8):1326-32.
18. LAMBERT B, BACHER K, DEFREYNE L. ET AL: 188Re-HDD/lipiodol therapy for hepatocellular carcinoma:
a phase I clinical trial. J Nucl Med. 2005 Jan 1;46(1):60-6.
19. LEE WC, WANG HC, HUNG CF. ET AL: Vaccination of advanced hepatocellular carcinoma patients
with tumor lysate-pulsed dendritic cells: a clinical trial. J Immunother. 2005 Sep-Oct;28(5):496-
504.
20. LIEM MS, POON RT, LO CM.ET AL: Outcome of transarterial chemoembolization in patients with
inoperable hepatocellular carcinoma eligible for radiofrequency ablation. World J Gastroenterol.
2005 Aug 7;11(29):4465-71.
21. LIM L, GIBBS P, YIP D.ET AL: Prospective study of treatment with selective internal radiation therapy
spheres in patients with unresectable primary or secondary hepatic malignancies. Intern Med
J 2005 Apr;35(4):222-7.
22. LIN AY, BROPHY N, FISHER GA.ET AL: Phase II study of thalidomide in patients with unresectable
hepatocellular carcinoma. Cancer. 2005 Jan 1;103(1):119-25.
23. MACKAY HJ, BILLINGSLEY K, GALLINGER S.ET AL: A multicenter phase II study of „adjuvant” irinotecan
following resection of colorectal hepatic metastases. Am J Clin Oncol. 2005 Dec;28(6):547-
54.
24. NOWAK AK, STOCKLER MR, CHOW PK.ET AL: Use of tamoxifen in advanced-stage hepatocellular
carcinoma. A systematic review. Cancer. 2005 Apr 1;103(7):1408-14. Review.
25. OSTAPENKO VV, TANAKA H, MIYANO M.ET AL: Immune-related effects of local hyperthermia in patients
with primary liver cancer. Hepatogastroenterology. 2005 Sep-Oct;52(65):1502-6.
26. PATT YZ, HASSAN MM, LOZANO RD.ET AL: Thalidomide in the treatment of patients with hepatocellular
carcinoma: a phase II trial. Cancer. 2005 Feb 15;103(4):749-55.
27. PAWLIK TM, POON RT, ABDALLA EK.ET AL: Hepatectomy for hepatocellular carcinoma with major
portal or hepatic vein invasion: results of a multicenter study. Surgery. 2005 Apr;137(4):403-
10.
28. POH SB, BAI LY, CHEN PM.: Pegylated liposomal doxorubicin-based combination chemotherapy
as salvage treatment in patients with advanced hepatocellular carcinoma. Am J Clin Oncol.
2005 Dec;28(6):540-6.
29. POKORNY H, GNANT M, RASOUL-ROCHENSCHAUB S. ET AL: Does additional doxorubicin chemotherapy
improve outcome in patients with hepatocellular carcinoma treated by liver transplantation?
Am J Transplant. 2005 Apr;5(4 Pt 1):788-94.
30. QIN B, KATO K, MITSUGI K. ET AL.: Feasibility study of ambulatory continuous infusion of 5-
fl uorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer.
Cancer Chemother Pharmacol. 2006 Jan;57(1):114-9.
31. SHIINA S, TERATANI T, OBI S. ET AL: A randomized controlled trial of radiofrequency ablation with
ethanol injection for small hepatocellular carcinoma. Gastroenterology. 2005 Jul;129(1):122-
30.
32. SHIMONOV M, HAYAT H, CHAITCHIK S. ET AL.: Combined systemic chronotherapy and hepatic artery
infusion for the treatment of metastatic colorectal cancer confi ned to the liver. Chemotherapy.
2005 May;51(2-3):111-5.
33. SLIJKHUIS WA, STADHEIM L, HASSOUN ZM.ET AL: Octreotide therapy for advanced hepatocellular
carcinoma. J Clin Gastroenterol. 2005 Apr;39(4):333-8.
34. SOGA K, SHIBASAKI K, AOYAGI Y.: Effect of interferon on incidence of hepatocellular carcinoma in
patients with chronic hepatitis C. Hepatogastroenterology. 2005 Jul-Aug;52(64):1154-8.
35. VALLE JW, DANGOOR A, BEECH J.ET AL: Treatment of inoperable hepatocellular carcinoma with
pegylated liposomal doxorubicin (PLD): results of a phase II study. Br J Cancer. 2005 Feb
28;92(4):628-30.
36. YEO W, MOK TS, ZEE B. ET AL: A randomized phase III study of doxorubicin versus cisplatin/
interferon alpha-2b/doxorubicin/fl uorouracil (PIAF) combination chemotherapy for unresectable
hepatocellular carcinoma. J Natl Cancer Inst. 2005 Oct 19;97(20):1532-8.
37. YIN XY, LU MD, LIANG LJ.ET AL: Systemic chemo-immunotherapy for advanced-stage hepatocellular
carcionoma. World J Gastroenterol. 2005 Apr 28;11(16):2526-9.
38. ZHU AX, FUCHS CS, CLARK JW. ET AL: A phase II study of epirubicin and thalidomide in unresectable
or metastatic hepatocellular carcinoma. Oncologist. 2005 Jun-Jul;10(6):392-8.
39. FOLPRECHT G, GROTHEY A, ALBERTS S ET AL: Neoadjuvant treatment of unresectable colorectal liver
metastases: correlation between tumour response and resection rates. Ann Oncol. 2005 May 3.
